Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
His resignation would be effective from March 18, 2024
The new ECO grade is made using renewable feedstock
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
Subscribe To Our Newsletter & Stay Updated